Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment. [electronic resource]
- Gene therapy 02 2021
- 6-15 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1476-5462
10.1038/s41434-020-0153-9 doi
CRISPR-Cas Systems Gene Editing Humans Retrospective Studies Technology beta-Globins--genetics beta-Thalassemia--genetics